Wednesday, April 24, 2013


Evonik is a leading specialty chemicals company. Profitable growth and a sustained increase in the value of the company form the heart of itsstrategy, which is supported by its owners, RAG-Stiftung (74.99 percent) and funds managed by CVC Capital Partners (25.01 percent). Evonik's specialty chemicals activities focus on high-growth megatrends—especially health, nutrition, resource efficiency, and globalization—and Evonik's goal is to enter attractive future-oriented markets. Click on the image to visit the Evonik website.

No comments:

Post a Comment